Key Financial Figures (Quarter Ended June 30, 2026)
Income Statement (₹ Lakhs):
- Revenue from operations: ₹4,696.84 (compared to ₹3,957.56 in Q1 FY2026 and ₹4,576.61 in Q4 FY2026)
- Other income: ₹55.98
- Total income: ₹4,752.82
- Total expenses: ₹4,429.51
- Profit before tax: ₹323.32 (compared to ₹228.87 in Q1 FY2026 and ₹230.89 in Q4 FY2026)
- Tax expense: ₹86.76 (Current tax: ₹67.60, Deferred tax: ₹19.16)
- Net profit after tax: ₹236.56 (compared to ₹149.86 in Q1 FY2026 and ₹187.69 in Q4 FY2026)
- Earnings per share (basic and diluted): ₹1.88
Balance Sheet Items:
- Paid-up equity share capital: ₹1,258.90 lakhs (face value ₹10 per share)
- Other equity (excluding revaluation reserve): ₹5,220.03 lakhs
Significant Updates and Events
1. Share Warrant Forfeiture:
The company had issued 15,00,000 convertible share warrants on December 5, 2024, at an issue price of ₹174 per warrant. Warrant holders paid 25% of the subscription amount (₹652.50 lakhs) upfront. The conversion period expired on June 5, 2026, without warrant holders exercising their option to pay the remaining 75% balance. Consequently, the board approved the forfeiture of these unexercised warrants at its meeting on June 18, 2026. The upfront amount of ₹652.50 lakhs was forfeited and transferred to capital reserve.
2. Merger Update:
The board had approved a scheme of arrangement for merger with Vitanosh Ingredients Private Limited on October 23, 2024. BSE Limited approved the scheme on March 28, 2025. Shareholders approved the scheme at an EOGM held on March 28, 2026. The merger remains pending final approvals from SEBI and the National Company Law Tribunal (NCLT). No effect of the proposed merger has been incorporated into these financial results.
Regulatory Compliance and Additional Information
- The company operates in one reportable business segment: Pharmaceuticals
- The financial results were prepared in accordance with Indian Accounting Standards (IND AS) 34
- Figures for previous periods have been reclassified/regrouped where necessary for comparability
- The full format of financial results is available on BSE's website and the company's website